High-Resolution Microendoscopy in Imaging Patients Undergoing Colposcopy for Abnormal Pap Test, HPV, or Cervical Dysplasia

This clinical trial studies a procedure called high-resolution microendoscopy (HRME) in imaging patients who are undergoing colposcopy because they received an abnormal Papanicolaou (Pap) test result, tested positive for human papillomavirus (HPV), or have a history of cervical dysplasia. HRME uses a fluorescent dye called proflavine hemisulfate that "lights up" the tissue of the cervix. A probe is then inserted that takes pictures of the cervix. This may allow doctors to study the cervix without performing surgery, and may help them identify abnormal tissue or cancer.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02420665.

Trial PhaseNo phase specified

Trial Typediagnostic

Lead OrganizationM D Anderson Cancer Center

Principal InvestigatorKathleen Marie Schmeler

• Primary ID2014-0368
• Secondary IDsNCI-2015-00681
• ClinicalTrials.gov IDNCT02420665